USA flag logo/image

An Official Website of the United States Government

Company Information:

Company Name:
U.S. DRUG TESTING LABORATORIES, INC.
Address:
1700 S MOUNT PROSPECT RD
DES PLAINES, IL 60018-1804
Phone:
N/A
URL:
N/A
EIN:
142161291
DUNS:
625689682
Number of Employees:
N/A
Woman-Owned?:
No
Minority-Owned?:
No
HUBZone-Owned?:
No

Commercialization:

Has been acquired/merged with?:
N/A
Has had Spin-off?:
N/A
Has Had IPO?:
N/A
Year of IPO:
N/A
Has Patents?:
N/A
Number of Patents:
N/A
Total Sales to Date $:
$ 0.00
Total Investment to Date $
$ 0.00
POC Title:
N/A
POC Name:
N/A
POC Phone:
N/A
POC Email:
N/A
Narrative:
N/A

Award Totals:

Program/Phase Award Amount ($) Number of Awards
SBIR Phase I $836,811.00 7
SBIR Phase II $2,033,781.00 2

Award List:

FETAL ALCOHOL EXPOSURE--COMMERCIAL ASSAY DEVELOPMENT

Award Year / Program / Phase:
1997 / SBIR / Phase I
Award Amount:
$99,954.00
Agency:
HHS
Principal Investigator:
Moore, christine m
Abstract:
Fetal alcohol syndrome (FAS) is the leading cause of preventable mental retardation in newborns in the U.S.A. The signs of extreme FAS include pre and post-natal growth retardation, neurological dysfunction and characteristic facial anomalies. Exposure to alcohol in utero may not result in… More

USING HUMAN HAIR TO DETERMINE LONG TERM ALCOHOL ABUSE

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Charles A. Plate
Abstract:
DESCRIPTION (provided by applicant): The objective of this project is to develop a diagnostic test to assess long-term alcohol consumption based on the analysis of hair for fatty acid ethyl esters. Excessive alcohol consumption causes damage to the liver, GI tract, central nervous system, pancreas,… More

DIAGNOSTIC VIABILITY OF UMBILICAL CORD SPECIMENS

Award Year / Program / Phase:
2004 / SBIR / Phase I
Award Amount:
$100,000.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The purpose of this project is to develop a diagnostic test to assess whether the umbilical cord can provide equivalent or superior information to meconium for the identification of fetal drug exposure. Maternal drug use causes numerous medical complications for… More

Diagnostic Viability of Umbilical Cord Specimens

Award Year / Program / Phase:
2006 / SBIR / Phase II
Award Amount:
$680,428.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): The current "best practices" procedure for diagnosing the in utero drug exposure of fetuses is testing the newborn's meconium for the presence of drugs. Meconium is difficult to collect and in 8-20% of births in the U.S. the meconium is released into the amniotic… More

Hair Ethyl Glucuronide as a Long Term Alcohol Biomarker

Award Year / Program / Phase:
2006 / SBIR / Phase I
Award Amount:
$107,577.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): There is a need for a highly sensitive (> 90%) and specific (> 90%) long term biomarker to both detect and monitor individuals who are heavy users of alcohol. Monitoring short term (3-5 days) alcohol use and abuse by impaired professionals by using urine ethyl… More

Phosphatidylethanol as an Alcohol Biomarker in Umbilical Cord Tissue

Award Year / Program / Phase:
2007 / SBIR / Phase I
Award Amount:
$109,639.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): Alcohol causes a wide range of fetal effects that have been designated fetal alcohol spectrum disorder (FASD). Children with FASD may benefit from early detection enabling them to receive early intervention and improv e their outcome. The current objective test… More

Phosphatidylethanol as an Alcohol Biomarker in Neonatal Blood Spots

Award Year / Program / Phase:
2008 / SBIR / Phase I
Award Amount:
$157,326.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): It is now well recognized that frequent and/or binge drinking of alcohol by a pregnant woman puts her fetus at high risk for birth defects. Moreover, the prevalence of binge drinking in women of childbearing-age seems to be increasing. While there is presently… More

Hair Ethyl Glucuronide as a Long Term Alcohol Biomarker

Award Year / Program / Phase:
2009 / SBIR / Phase II
Award Amount:
$1,353,353.00
Agency:
HHS
Principal Investigator:
Abstract:
DESCRIPTION (provided by applicant): There currently is a real need for a long term and objective alcohol biomarker to both monitor alcohol-impaired healthcare professionals, and to aid in the selection of organ transplant recipients, particularly liver tr ansplant recipients. We recently concluded… More

Novel SET Antagonists for the Treatment of Chronic Myelogenous Leukemia

Award Year / Program / Phase:
2013 / SBIR / Phase I
Award Amount:
$162,315.00
Agency:
HHS
Principal Investigator:
Aileen E. Baldwin – 872-226-6965
Abstract:
PROJECT SUMMARY Prenatal alcohol exposure is the leading preventable cause of birth defects in the United States, producing an array of neurological, behavioral and physical abnormalities collectively known as fetal alcohol spectrum disorders (FASD). Earlyintervention and treatment programs have… More